- Home
- BG vs VRNA Comparison
BG vs VRNA Comparison
Compare BG & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BG
- VRNA
- Stock Information
- Founded
- BG 1818
- VRNA 2005
- Country
- BG United States
- VRNA United Kingdom
- Employees
- BG 23000
- VRNA N/A
- Industry
- BG Packaged Foods
- VRNA Biotechnology: Pharmaceutical Preparations
- Sector
- BG Consumer Staples
- VRNA Health Care
- Exchange
- BG Nasdaq
- VRNA Nasdaq
- Market Cap
- BG 11.1B
- VRNA 8.3B
- IPO Year
- BG N/A
- VRNA 2017
- Fundamental
- Price
- BG $78.44
- VRNA $91.89
- Analyst Decision
- BG Buy
- VRNA Strong Buy
- Analyst Count
- BG 5
- VRNA 9
- Target Price
- BG $81.60
- VRNA $112.56
- AVG Volume (30 Days)
- BG 2.0M
- VRNA 1.1M
- Earning Date
- BG 07-30-2025
- VRNA 08-07-2025
- Dividend Yield
- BG 3.57%
- VRNA N/A
- EPS Growth
- BG N/A
- VRNA N/A
- EPS
- BG 7.82
- VRNA N/A
- Revenue
- BG $51,334,000,000.00
- VRNA $118,535,000.00
- Revenue This Year
- BG $0.06
- VRNA $891.79
- Revenue Next Year
- BG $3.22
- VRNA $78.94
- P/E Ratio
- BG $10.03
- VRNA N/A
- Revenue Growth
- BG N/A
- VRNA N/A
- 52 Week Low
- BG $67.40
- VRNA $15.15
- 52 Week High
- BG $114.92
- VRNA $99.01
- Technical
- Relative Strength Index (RSI)
- BG 48.03
- VRNA 55.59
- Support Level
- BG $78.76
- VRNA $92.88
- Resistance Level
- BG $83.42
- VRNA $97.44
- Average True Range (ATR)
- BG 2.50
- VRNA 3.34
- MACD
- BG -0.33
- VRNA -1.05
- Stochastic Oscillator
- BG 27.66
- VRNA 9.89
About BG Bunge Limited
Bunge Global SA formerly Bunge Ltd is an agribusiness and food company with operations along the farm-to-consumer food chain. The company segments include Agribusiness; Refined and Specialty Oils; Milling; Sugar and Bioenergy and Corporate and Other. It generates maximum revenue from the Agribusiness segment. The company is an oilseed processor and producer of vegetable oils and protein meals, based on processing capacity, a grain processor, the seller of packaged plant-based oils, producer and seller of wheat flour, bakery mixes and corn-based products in North and South America.
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.